Valeant vs Medicis - Valeant to buy Medicis for $2.6bn Canadian pharmaceutical group aims to bolster its skincare business and capitalise on an ageing US population with the planned acquisition Source: Pharmaceuticals companies news from the Financial Times Psychology, Special Needs & Health.